Factor XIII (CSL Behring)

N/A

Report date: 2022/04/12 18:38:48

Base Information

Drug NameFactor XIII (CSL Behring)
Drug Alias NameBlood coagulation factor XIII-CSL BehringCoagulation factor XIII-CSL BehringFibrin stabilising factor-CSL BehringCorifactFibrogammin-P
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionFactor XIII replacements
TargetsFibrinogen
Therapy Area/IndicationsHemorrhageScleroderma, SystemicFactor XIII Deficiency
Global Approved IndicationsHemorrhageFactor XIII Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1994/09/01
Country/TerritoryUnited StatesUnited KingdomSpain +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesCsl BehringUniversity College London
Active IndicationsHemorrhageFactor XIII Deficiency
Inactive IndicationsScleroderma, Systemic

Other Information

ATC CodeB02BD07
Related LinksWikipediaDrugBankKEGG